A committee for the European Medicines Agency (EMA) has recommended suspending entirely or restricting the use of fluoroquinolone and quinolone antibiotics because of the risk for "disabling and ...

The European Medicine Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of systemic and inhaled fluoroquinolone and quinolone antibiotics following ...

(Reuters) - The European Medicines Agency's risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following a review of side ...

GPs could see tighter controls placed on quinolone antibiotics from next year, after the European Medicines Agency called for certain medicines containing this class of antibiotics to be suspended, ...

I've been following fluoroquinolone antibiotics ever since I was a graduate student in the 1980s. We were working on a class of enzymes shared by bacteria and higher organisms called topoisomerases.

CHARLOTTE, N.C., Sept. 26, 2016 /PRNewswire-iReach/ -- The Food and Drug Administration (FDA) strengthened warning labels on July 26, 2016 and issued a limitation-of-use directive on fluoroquinolone ...

Most of us take antibiotics, grateful for a reliable cure, with little thought for the potential side-effects. But concerns are mounting about adverse reactions caused by a group of widely prescribed ...

After a review of serious side effects, the agency decided to suspend marketing authorizations for quinolone and fluoroquinolone antibiotics and restrict use of remaining fluoroquinolone antibiotics.

Patients taking fluoroquinolone antibiotics such as norfloxacin exhibit a low incidence of convulsions and anxiety. These side effects probably result from antagonism of the neurotransmitter ...